The cardiovascular response of normal humans to the administration of endotoxin.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  New England Journal of Medicine

• Publication date

  1989-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198908033210503PMID 2664516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock.

  1989cited by this paper
• Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

  1989cited by this paper
• Responses of left ventricular function in survivors and nonsurvivors of septic shock

  1989cited by this paper
• Left ventricular contractility varies directly with blood ionized calcium.

  1988cited by this paper
• Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock.

  1988cited by this paper
• Endotoxaemia: an early predictor of septicaemia in febrile patients.

  1988cited by this paper
• Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.

  1987cited by this paper
• Cachectin: more than a tumor necrosis factor.

  1987cited by this paper
• Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.

  1987cited by this paper
• Hemodynamic response to fluid repletion in patients with septic shock: evidence for early depression of cardiac performance.

  1987cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

  1987cited by this paper
• Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.

  1987cited by this paper
• Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

  1987cited by this paper
• Sweating, hemodynamic responses, and thermal equilibration during hyperthermia in humans.

  1987cited by this paper
• A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

  1986cited by this paper
• The coronary circulation in human septic shock.

  1986cited by this paper
• Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.

  1986cited by this paper
• Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

  1985cited by this paper
• A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.

  1985cited by this paper
• Left ventricular performance in septic shock: reversible segmental and global abnormalities.

  1985cited by this paper
• Profound but reversible myocardial depression in patients with septic shock.

  1984cited by this paper
• The uses and limitations of end-systolic indexes of left ventricular function.

  1984cited by this paper
• The processing and collaborative assay of a reference endotoxin.

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

  1982cited by this paper
• Improved Left Ventricular Diastolic Filling in Patients with Coronary Artery Disease After Percutaneous Transluminal Coronary Angioplasty

  1982cited by this paper
• Does the pulmonary capillary wedge pressure predict left ventricular preload in critically ill patients?

  1981cited by this paper
• Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans.

  1981cited by this paper
• Sepsis and septic shock--a review of laboratory models and a proposal.

  1980cited by this paper
• Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients

  1980cited by this paper
• Heart Disease: A Textbook of Cardiovascular Medicine

  1979cited by this paper
• Letter: Procaine and malignant hyperthermia.

  1974cited by this paper
• Nonparametric Statistical Methods: Hollander/Nonparametric Statistical Methods

  1973cited by this paper
• Introduction to Probability Theory

  1972cited by this paper
• Direct Cardiac Action of E. coli Endotoxin

  1972cited by this paper
• On the Combination of Independent Test Statistics

  1967cited by this paper
• Contractility of the heart in abnormal temperatures.

  1966cited by this paper
• Cardiopulmonary consequences of pyrogen-induced hyperpyrexia in man.

  1963cited by this paper
• Cardiac and peripheral vascular responses to hyperthermia induced by blood stream heating.

  1962cited by this paper
• Mechanisms of the hemodynamic effects of endotoxin.

  1960cited by this paper
• HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION.

  1945cited by this paper

• The effect of plasma versus crystalloids on intravascular volume, tissue perfusion and tissue oxygenation: a randomized controlled trial in a human endotoxemia model.

  2026cites this paper
• Impaired endotoxin inactivation, rather than gut translocation, is associated with organ injury in cardiac surgery with cardiopulmonary bypass: An ancilliary analysis of a randomised control trial.

  2026cites this paper
• The effects of extracorporeal blood purification (oXiris®) in patients with cardiogenic shock who require VA-ECMO (CLEAN ECMO): a prospective, open-label, randomized controlled pilot study

  2025cites this paper
• Definition of Sepsis-Induced Myocardial Dysfunction and Research Progress of Its Biomarkers

  2025cites this paper
• Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management

  2025cites this paper
• Sepsis-induced cardiomyopathy.

  2025cites this paper
• Coxsackie and adenovirus receptor is a novel regulator of inflammatory response in endotoxin-induced failing heart.

  2025cites this paper
• Sepsis-induced cardiomyopathy: Time to bring the heart back to the forefront.

  2025cites this paper
• Laboratory and Microbiological Considerations in Sepsis-Induced Cardiac Dysfunction

  2025cites this paper
• Heart-lung crosstalk in acute respiratory distress syndrome

  2024cites this paper
• Nicotinamide mononucleotide protects septic hearts in mice via preventing cyclophilin F modification and lysosomal dysfunction

  2024cites this paper
• Divergent effects of tumor necrosis factor (TNF) in sepsis: a meta-analysis of experimental studies

  2024influential citation
• Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction

  2024cites this paper
• The Protective Effects of Ruscogenin Against Lipopolysaccharide-Induced Myocardial Injury in Septic Mice

  2024cites this paper
• Fast, Easy, and Reproducible Fingerprint Methods for Endotoxin Characterization in Nanocellulose and Alginate-Based Hydrogel Scaffolds

  2024cites this paper
• Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge

  2024cites this paper
• Sepsis induced cardiotoxicity by promoting cardiomyocyte cuproptosis.

  2023cites this paper
• NLRP3 inflammasome-driven IL-1β and IL-18 contribute to lipopolysaccharide-induced septic cardiomyopathy.

  2023cites this paper
• Clinical implications of endotoxin activity and Polymyxin-B hemoperfusion in critically ill patients with septic cardiomyopathy: A single-center, retrospective, observational study.

  2023cites this paper
• INVASIVE HEMODYNAMIC MONITORING WITH PULMONARY ARTERY CATHETER IN SEPSIS-ASSOCIATED CARDIOGENIC SHOCK

  2023cites this paper
• Melatonin as a potential treatment for septic cardiomyopathy.

  2023cites this paper
• How to use echocardiography to manage patients with shock?

  2023cites this paper
• Endotoxemia in Acute Heart Failure and Cardiogenic Shock: Evidence, Mechanisms and Therapeutic Options

  2023cites this paper
• Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut–Heart Axis

  2023cites this paper
• Sensitive and rapid detection of bacterial endotoxin with a functional carbon nanotube field-effect transistor biosensor.

  2023cites this paper
• Extending the ‘host response’ paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities

  2023cites this paper
• Pathophysiological responses to bloodstream infection in critically ill transplant recipients compared to non-transplant recipients.

  2023cites this paper
• Lipid oxidation dysregulation: an emerging player in the pathophysiology of sepsis

  2023cites this paper
• A Study of Impact of Fixed-Dose Albumin Infusion on Outcome in Patients With Cirrhosis and Infection: A Randomized Open-label Clinical Trial.

  2023cites this paper
• Engineer a double team of short-lived and glucose-sensing bacteria for cancer eradication

  2023cites this paper
• Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia

  2022cites this paper
• The gut microbiome and cardiac surgery an unusual symphony

  2022cites this paper
• The Rationale and Current Status of Endotoxin Adsorption in the Treatment of Septic Shock

  2022cites this paper
• Development of a Simple and Effective Lipid-A Antagonist Based on Computational Prediction.

  2022cites this paper
• The Effect of Sepsis on Myocardial Function: A Review of Pathophysiology, Diagnostic Criteria, and Treatment

  2022cites this paper
• Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release.

  2022cites this paper
• Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant.

  2022cites this paper
• Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting

  2022cites this paper
• Septic cardiomyopathy: characteristics, evaluation, and mechanism

  2022cites this paper
• Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.

  2022cites this paper
• Relative bradycardia in patients with COVID-19

  2022cites this paper
• Evidence of myocardial injury in horses with colic

  2021cites this paper
• Fluid resuscitation in ovine sepsis: re-examining the role of a common resuscitation therapy

  2021cites this paper
• Astragaloside IV Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction in Rats via IKK/NF-κB Pathway

  2021cites this paper
• Early Vitamin C, Hydrocortisone, and Thiamine Treatment for Septic Cardiomyopathy: A Propensity Score Analysis

  2021cites this paper
• Pathophysiology of Sepsis and Heart-Lung Interactions: Part 2, Treatment

  2021cites this paper
• Protective effect of Apelin/APJ system on lipopolysaccharide-related cardiac dysfunction.

  2021cites this paper
• Aldehyde Dehydrogenase 2 Protects Against Lipopolysaccharide-Induced Myocardial Injury by Suppressing Mitophagy

  2021cites this paper
• The effectiveness and feasibility of fluid resuscitation directed by microcirculation monitoring in patients with septic shock: a randomized controlled trial.

  2021cites this paper
• Cardiovascular Responses During Sepsis.

  2021cites this paper
• Automated blood sampling in canine telemetry model: Enhanced assessment of immune liabilities.

  2021cites this paper
• Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes

  2021cites this paper
• Regulatory role of the TLR4/JNK signaling pathway in sepsis-induced myocardial dysfunction

  2021cites this paper
• Pathophysiology of Sepsis and Heart-Lung Interactions: Part 1, Presentation and Mechanisms

  2021cites this paper
• Pinocembrin alleviates lipopolysaccharide-induced myocardial injury and cardiac dysfunction in rats by inhibiting p38/JNK MAPK pathway.

  2021cites this paper
• Impact of lipopolysaccharide administration on luteinizing hormone/choriogonadotropin receptor (Lhcgr) expression in mouse ovaries.

  2020cites this paper
• Dynamic predictions of postoperative complications from explainable, uncertainty-aware, and multi-task deep neural networks

  2020cites this paper
• Use of perfusion index to detect hemodynamic changes in endotoxemic pigs.

  2020cites this paper
• Preterm birth and sustained inflammation: consequences for the neonate

  2020cites this paper
• Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis

  2020cites this paper
• Calpain Activation and Organ Failure in Sepsis: Molecular Insights and Therapeutic Perspectives

  2020cites this paper
• Pathophysiologic Signatures of Bloodstream Infection in Critically Ill Adults

  2020cites this paper
• Rethinking animal models of sepsis – working towards improved clinical translation whilst integrating the 3Rs

  2020cites this paper
• Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation

  2020cites this paper
• Effect of Vasopressors on The Macro- and Microcirculation During Systemic Inflammation In Humans in vivo.

  2020cites this paper
• Monitoring coherence between the macro and microcirculation in septic shock.

  2020cites this paper
• Challenging the challenge: a randomized controlled trial evaluating the inflammatory response and pain perception of healthy volunteers after single-dose LPS administration, as a potential model for inflammatory pain in early-phase drug development.

  2020cites this paper
• Clinical outcomes of severe sepsis and septic shock patients with left ventricular dysfunction undergoing continuous renal replacement therapy

  2020influential citation
• CTRP12 Ameliorated Lipopolysaccharide-Induced Cardiomyocyte Injury.

  2020cites this paper
• Systemic inflammation and sepsis. Part I: Storm formation.

  2020cites this paper
• The role of vagus nerve stimulation in sepsis

  2020cites this paper
• Extraction, Quantification, and Cytokine Inhibitory Response of Bakuchiol in Psoralea coryfolia Linn.

  2020cites this paper
• Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery

  2020cites this paper
• Endotoxemia-Induced Release of Pro-inflammatory Mediators Are Associated With Increased Glomerular Filtration Rate in Humans in vivo

  2020cites this paper
• Myocardial Stunning

  2019cites this paper
• Attenuation of Sepsis-Induced Cardiomyopathy by Regulation of MicroRNA-23b Is Mediated Through Targeting of MyD88-Mediated NF-κB Activation

  2019cites this paper
• Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier 'sodium deoxycholate sulfate'.

  2019cites this paper
• Value of speckle-tracking echocardiography changes in monitoring myocardial dysfunction during treatment of sepsis: potential prognostic implications

  2019cites this paper
• Should endotoxin be a research priority in Gram-negative sepsis and septic shock?

  2019cites this paper
• Nonhuman primate species as models of human bacterial sepsis

  2019cites this paper
• P-AKT2/SPK1 (P-SPK1) and P-MEK/P-ERK cell signaling pathways are involved in LPS-induced macrophage migration.

  2019cites this paper
• Analysis of cytokine concentration and the visual analogue pain scale score as early indicators of sepsis in gall stone disease patients : evaluating quality of life questionnaires to determine which patients will experience significant pain after intervention

  2019cites this paper
• Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1

  2019cites this paper
• Phage Therapy in the Twenty-First Century: Facing the Decline of The Antibiotic Era; Is it Finally Time for The Age of the Phage?

  2019cites this paper
• The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications

  2019cites this paper
• Zytokinaktivierung in der Herzinsuffizienz F . Beitz

  2019cites this paper
• Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1

  2019cites this paper
• Endotoxin Removal in Septic Shock with the Alteco® LPS Adsorber was Safe But Showed No Benefit Compared to Placebo in the Double-Blind Randomized Controlled Trial - the Asset Study.

  2019cites this paper
• Dynamic Cerebral Autoregulation and Critical Closing Pressure in Experimental Human Endotoxemia and Sepsis Patients

  2019cites this paper
• Abdominal organ perfusion and inflammation in experimental sepsis: a magnetic resonance imaging study.

  2019cites this paper
• Septische Kreislaufinsuffizienz

  2019cites this paper
• Cardiomyopathie septique et assistance circulatoire : revue de la littérature et expérience lyonnaise sur 12 ans

  2019cites this paper
• Humoral Mediators in Sepsis

  2019cites this paper
• Experimental human endotoxemia as a model of systemic inflammation.

  2019cites this paper
• Differing toxicity of ambient particulate matter (PM) in global cities

  2019cites this paper
• An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction.

  2019cites this paper
• Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis

  2019cites this paper
• Myocardial depression in a calf with septic shock

  2018cites this paper
• Chapter 33 – The Failing Myocardium in Sepsis

  2018cites this paper
• The systemic inflammatory response syndrome

  2018cites this paper